PNC Financial Services Group’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.57M | Sell |
6,873
-1,826
| -21% | -$409K | ﹤0.01% | 1097 |
|
|
2025
Q4 | $1.85M | Buy |
8,699
+584
| +7% | +$121K | ﹤0.01% | 1001 |
|
|
2025
Q3 | $1.61M | Buy |
8,115
+414
| +5% | +$77.2K | ﹤0.01% | 1039 |
|
|
2025
Q2 | $1.33M | Sell |
7,701
-877
| -10% | -$143K | ﹤0.01% | 1076 |
|
|
2025
Q1 | $1.34M | Buy |
8,578
+195
| +2% | +$27.9K | ﹤0.01% | 1056 |
|
|
2024
Q4 | $1.15M | Sell |
8,383
-442
| -5% | -$58.1K | ﹤0.01% | 1112 |
|
|
2024
Q3 | $1.32M | Sell |
8,825
-26
| -0.3% | -$3.51K | ﹤0.01% | 1066 |
|
|
2024
Q2 | $1.21M | Sell |
8,851
-2,801
| -24% | -$381K | ﹤0.01% | 1069 |
|
|
2024
Q1 | $1.76M | Sell |
11,652
-4,732
| -29% | -$675K | ﹤0.01% | 947 |
|
|
2023
Q4 | $2.06M | Buy |
16,384
+159
| +1% | +$15.9K | ﹤0.01% | 873 |
|
|
2023
Q3 | $1.52M | Buy |
16,225
+457
| +3% | +$42.8K | ﹤0.01% | 944 |
|
|
2023
Q2 | $1.41M | Buy |
15,768
+1,921
| +14% | +$167K | ﹤0.01% | 1013 |
|
|
2023
Q1 | $1.48M | Buy |
13,847
+1,526
| +12% | +$175K | ﹤0.01% | 967 |
|
|
2022
Q4 | $1.5M | Sell |
12,321
-220
| -2% | -$25.5K | ﹤0.01% | 965 |
|
|
2022
Q3 | $1.29M | Buy |
12,541
+1,407
| +13% | +$133K | ﹤0.01% | 1007 |
|
|
2022
Q2 | $1.04M | Buy |
11,134
+2,240
| +25% | +$211K | ﹤0.01% | 1141 |
|
|
2022
Q1 | $1.04M | Sell |
8,894
-738
| -8% | -$85.5K | ﹤0.01% | 1218 |
|
|
2021
Q4 | $1.3M | Buy |
9,632
+339
| +4% | +$50.4K | ﹤0.01% | 1146 |
|
|
2021
Q3 | $1.48M | Buy |
9,293
+1,343
| +17% | +$184K | ﹤0.01% | 1018 |
|
|
2021
Q2 | $1.05M | Buy |
7,950
+534
| +7% | +$71.2K | ﹤0.01% | 1172 |
|
|
2021
Q1 | $956K | Buy |
7,416
+2,117
| +40% | +$322K | ﹤0.01% | 1177 |
|
|
2020
Q4 | $884K | Sell |
5,299
-623
| -11% | -$103K | ﹤0.01% | 1175 |
|
|
2020
Q3 | $914K | Sell |
5,922
-144
| -2% | -$20.7K | ﹤0.01% | 1081 |
|
|
2020
Q2 | $896K | Sell |
6,066
-138
| -2% | -$18.9K | ﹤0.01% | 1082 |
|
|
2020
Q1 | $699K | Buy |
6,204
+382
| +7% | +$49.6K | ﹤0.01% | 1127 |
|
|
2019
Q4 | $811K | Buy |
5,822
+11
| +0.2% | +$1.22K | ﹤0.01% | 1186 |
|
|
2019
Q3 | $559K | Buy |
5,811
+208
| +4% | +$23.2K | ﹤0.01% | 1538 |
|
|
2019
Q2 | $644K | Buy |
5,603
+1,983
| +55% | +$237K | ﹤0.01% | 1484 |
|
|
2019
Q1 | $426K | Sell |
3,620
-2,820
| -44% | -$247K | ﹤0.01% | 1717 |
|
|
2018
Q4 | $404K | Sell |
6,440
-320
| -5% | -$20.1K | ﹤0.01% | 1663 |
|
|
2018
Q3 | $480K | Buy |
6,760
+1,500
| +29% | +$103K | ﹤0.01% | 1688 |
|
|
2018
Q2 | $350K | Buy |
+5,260
| New | +$346K | ﹤0.01% | 1860 |
|
Other funds holding ASND
RCM
ACA
